Wenbin Ma

Dr. Wenbin Ma

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
DZDong-Hua Zeng
Dong-Hua Zeng
DYDong-Ni Yuan
Dong-Ni Yuan
QZQian-Qian Zhou
Qian-Qian Zhou
YLYun-Yu Liu
Yun-Yu Liu
WMWenbin Ma
Wenbin Ma
LLLei Lan
Lei Lan
Purpose: Knee joint pain severely affects patients’ quality of life and mental health and is a major factor in their seeking medical treatment. Given the increasing interest in non-invasive and complementary therapies for knee osteoarthritis, we conducted a systematic literature review and a meta-analysis of randomized clinical trials (RCTs) to evaluate the analgesic efficacy of laser acupuncture for knee osteoarthritis. Methods: Data were searched from Cochrane CENTRAL, PubMed, EMBASE, MEDLINE, and three Chinese databases from inception to September 10, 2024, for RCTs of acupuncture for KOA. Paired reviewers independently extracted data and assessed the risk of bias. We used random effects models for all meta-analyses and the GRADE approach to assess the certainty of evidence. Results: We included 5 RCTs (293 participants, 57% females). Low certainty evidence suggested that laser acupuncture may have no or little effects on reducing pain intensity compared to exercise (weighted mean difference [WMD] − 0.84 cm on a 10 cm Visual Analogue Scale [VAS], 95% CI − 1.12 to − 0.56 cm; laser acupuncture may reduce more pain intensity compared to placebo laser acupuncture (WMD − 2.33 cm, 95% CI − 3.57 to − 1.09 cm). Low evidence showed that laser acupuncture may improve the knee functioning of KOA patients compared to placebo acupuncture on 240-point WOMAC (WMD − 39.06, 95% CI − 63.79 to − 14.32). Conclusion: Based on the low-certainty evidence from our meta-analysis, the effects of laser acupuncture on pain intensity compared to exercise are uncertain. However, compared to placebo laser acupuncture, laser acupuncture may lead to greater pain reduction and improved knee functioning in KOA patients. Due to the limited number of included studies and the low certainty of evidence, further high-quality RCTs are needed to confirm these findings.

21 July 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
WMWenbin Ma
Wenbin Ma
RRRalf Regenthal
Ralf Regenthal
UKUte Krügel
Ute Krügel
Background and Objectives: Mental health and healthy eating are inextricably linked by bi-directional interaction. As pharmacological interventions for eating disorders and mental illness have limited efficacy and are associated with significant side effects, natural compounds traditionally used in these fields represent an extremely rich source for potential future drugs. This review aims to summarise complex and/or specific pharmacological and clinical effects of mixed compositions and individual compounds derived from Rosmarinus officinalis, Ginkgo biloba, and Bupleurum chinense as well as from Berberis vulgaris and other berberine (BBR)-containing plants, which have been traditionally used for eating and mental health purposes. Results and Conclusions: The data on favoured natural compounds and main ingredients of compound mixtures presented here could provide new impetus for preventive or targeted supplementary treatment, potential drug development, and the design of new compound congeners with improved target spectrum and potency in mental health disorders and eating-related issues. Contemporary methodological development steps in this direction are then proposed.

1 October 2025 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
DZDong-Hua Zeng
Dong-Hua Zeng
DYDong-Ni Yuan
Dong-Ni Yuan
QZQian-Qian Zhou
Qian-Qian Zhou
YLYun-Yu Liu
Yun-Yu Liu
WMWenbin Ma
Wenbin Ma
LLLei Lan
Lei Lan
Response to Letter in regards to Interpreting the Evidence for Laser Acupuncture in Knee Osteoarthritis Management: A Call for Methodological Rigor and Nuance [Letter]

1 February 2026 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
XLXing-Xian Li
Xing-Xian Li
ZHZhuo-Ya Hu
Zhuo-Ya Hu
DYDong-Ni Yuan
Dong-Ni Yuan
JZJun-Xin Zhao
Jun-Xin Zhao
WMWenbin Ma
Wenbin Ma
LLLei Lan
Lei Lan
Obesity is common in women with polycystic ovary syndrome (PCOS) and can exacerbate PCOS symptoms. Although Acupoint catgut embedding (ACE) is frequently used to treat the clinical symptoms of simple obesity, it is unclear how it will affect obesity associated with PCOS. We conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) to evaluate the effectiveness of ACE in treating obesity in women with PCOS. We searched databases from inception to January 8, 2025. Two independent reviewers extracted data and assessed the risk of bias. All meta-analyses used random effects models, and the GRADE approach was used to assess the certainty of the evidence. We included 25 RCTs (1,663 participants). Based on usual care, compared to blank treatment, ACE probably reduces body mass index (BMI), waist-to-hip ratio (WHR), and waist circumference (WC), and may enable a greater proportion of patients to achieve a weight loss no less than 5% (relative risk [RR] 1.33, 95% CI 1.15 to 1.55) and may reduce triglycerides (TG). Furthermore, when compared to active comparators, ACE probably enables a greater proportion of patients to achieve a weight loss no less than 5% (RR 1.40, 95% CI 1.11 to 1.76) and reduces WC and may also reduce BMI and TG. All effects were supported by low to moderate certainty evidence. When compared to blank treatment, on the basis of usual care, ACE for obesity associated with PCOS may improve obesity-related outcomes. When compared to active comparators, it may have comparable or greater therapeutic efficacy and fewer adverse events. Such improvements in obesity-related indicators may help alleviate metabolic and reproductive symptoms in women with PCOS. As all included trials were conducted in China, further high-quality studies in diverse populations are needed to confirm the generalizability of these findings.

14 October 2026 in Purinergic Signalling
Verified
Journal Article
Open access
PDF file
RLRui Li
Rui Li
HXHai-Yun Xiong
Hai-Yun Xiong
SCShi-Yu Chen
Shi-Yu Chen
YTYong Tang
Yong Tang
WMWenbin Ma
Wenbin Ma
Purinergic signaling has been widely recognized as a critical regulator of tumor progression, yet the role of P2Y14R in cervical cancer remains unclear. This study used the P2Y14R antagonist PPTN in in vitro cell experiments; the results showed that it significantly inhibited cell proliferation and increased LDH release. The anti-tumor effect of P2Y14R antagonism was further validated using a cervical cancer organoid model. Mechanistically, PPTN treatment elevated intracellular cAMP levels, enhanced the phosphorylation of PKA and CREB, and thereby activated the cAMP/PKA/CREB signaling axis. Moreover, PPTN intervention reduced Ki67 expression in cervical cancer organoids without affecting CK13 expression, suggesting that the anti-tumor effect of PPTN may not mediated through regulation of differentiation. Collectively, these findings identify P2Y14R as a novel regulator of the cAMP/PKA/CREB signaling pathway in cervical cancer cells, providing a promising therapeutic target for cervical cancer.